Clinical Data Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment BioSpaceCOVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data.Clinical DataInfectious DiseaseRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) BioSpace COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data. Clinical DataInfectious DiseaseRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: AZ claims another win for Imfinzi in frontline liver cancerNext: Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling Related Stories Clinical Data AstraZeneca, Ionis drug fails big heart disease study in major setback pharminent July 9, 2026 Clinical Data Roche’s KRAS drug tops its rivals in lung cancer trial pharminent July 2, 2026 Clinical Data EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s pharminent July 1, 2026
